By
Drug Target Review2024-02-19T12:00:29
Researchers have created a novel molecule, which has an improved ability to bind to bacterial ribosomes, with a completely synthetic system.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-22T07:38:00Z
Contributor Dr Helen Bright, By Drug Target Review
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-07-04T10:05:58
Sponsored by Revvity
2023-03-07T10:55:58
Sponsored by Agilent
2023-07-11T16:13:06
Sponsored by Agilent
2023-04-04T15:03:09
Sponsored by Agilent
Site powered by Webvision Cloud